In positive expiratory pressure (PEP), a person breathes through a mask or a handheld mouthpiece. PEP devices allow air to flow freely as person breathes in, but not when person breathe out.
Rise in lung diseases associated patients in hospitals and rapid technological advancement in medical devices are major factors expected to drive the growth of global positive expiratory pressure (PEP) devices market. According to WHO, respiratory tract infections caused by influenza kill between 250,000 and 500,000 people and cost between US$71 and 167 billion annually. The most common lethal neoplasm in the world is lung cancer, which kills 1.6 million people each year. COPD is the third leading cause of death by disease in the United States. More than 16.4 million people have been diagnosed with COPD, but millions more may have the disease without even knowing it. COPD causes serious long-term disability and early death. Government of developed and developing countries is spending high in development on present infrastructure. With the high per capita spending on healthcare and availability of favorable reimbursement policies is resulting in consumers approach towards homecare settings this is expected to boost the growth of positive expiratory pressure (PEP) devices market. Spending for freestanding home health care agencies increased 4.3 percent in 2017, the same rate as 2016, to US$ 97.0 Bn. U.S. home health spending officially hit US$102.2 billion in 2018. Major players are investing high for product development their approach towards enhancing the business through introduction of innovative solutions is expected to augment the growth of target market. In 2021, Smiths Medical, a leading medical device manufacturer launched “Acapella” choice blue vibratory PEP therapy system. Acapella is designed to aid in the removal of secretions for patients who have Cystic Fibrosis, Chronic Obstructive Pulmonary Disease (COPD), asthma, lung disease with secretory problems, and patients with atelectasis. The product launch is expected to help the company to enhance the business and increase the revenue share.
In 2021, AirPhysio, a global medical device company partnered with GiddyUp an e-commerce firm. The partnership is focused on enhancing the company presence online where GetAirPhysio.io, a website dedicated to selling the product at discount rates. This is expected to help the company to increase the customer base.
Approach of major players towards developing countries in order to increase the revenue is growing. Favorable business policies by the government and emergence of small & mid-size enterprises with innovative solutions are factors expected to support the growth of target market. Factors such as stringent government regulations related to product approval and low reliability of consumers are expected to hamper the growth of global positive expiratory pressure (PEP) devices market. In addition, high cost associated to production is expected to challenge the growth of target market. However, increasing investment by major players for product development and focus on implementation of AI in devices are factors expected to create new opportunities for players operating in the positive expiratory pressure (PEP) devices market over the forecast period. In addition, increasing partnership activities between regional and international players in order to strengthen the distribution channel is expected to support the revenue transaction of the target market.
Segment Analysis by Region
The market in North America is expected to account for major revenue share in the global positive expiratory pressure (PEP) devices market due to high patient pool suffering from lung associated diseases. In addition, presence of large number of players operating in the country and introduction of innovative solutions is expected to support the regional market growth. In addition, increasing acquisition activities by players with the focus to enhance the business is expected to support the regional market growth.
The global positive expiratory pressure (PEP) devices market is highly competitive due to presence of large number of players and innovative product offerings. In addition, business expansion activities through partnerships and agreements are factors expected to further increase the competition.
Positive Expiratory Pressure (PEP) Devices Market Segment Analysis, 2019
The global positive expiratory pressure (PEP) devices market is segmented into therapy type, product type, pressure type, application, and distribution channel. The application segment of global positive expiratory pressure (PEP) devices market is bifurcated into Atelectasis, Bronchiectasis, Bronchitis, Cystic Fibrosis, Asthma, and COPD. The pressure type segment is divided into high positive expiratory pressure (HiPEP) and oscillatory positive expiratory pressure (OscPEP). The players profiled in the report are Smiths Medical, Aptalis Pharma US Inc., Philips Respironics, Monaghan Medical, D R Burton Healthcare Products LLC, and Pari Respiratory Equipment, Inc.
Market By Therapy Type
High Positive Expiratory Pressure (HiPEP)
Oscillatory Positive Expiratory Pressure (OscPEP)
Market By Product Type
Market By Pressure Type
High Pressure PEP (26-102cm H2O)
Low Pressure PEP (5-20cm H2O)
Market By Application
Market By Distribution Channel
Market By Geography
• Rest of Europe
• South Korea
• Rest of Asia-Pacific
• Rest of Latin America
Middle East & Africa
• South Africa
• Rest of Middle East & Africa
Rise in lung diseases associated patients in hospitals and rapid technological advancement in medical devices are major factors expected to drive the growth of global positive expiratory pressure (PEP) devices market.
In application the COPD segment is growing at faster pace.
In the global market the Asia Pacific region is expected to grow faster.
Some of the players considered in the report scope are Smiths Medical, Aptalis Pharma US Inc., Philips Respironics, and Monaghan Medical.
The North America is expected to account for major revenue share in the global market.
In distribution channel the hospital pharmacy segment is growing at faster pace.
Factors such as stringent government regulations related to product approval and low reliability of consumers are expected to hamper the growth of global positive expiratory pressure (PEP) devices market.